Raymond James & Associates’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.13M | Sell |
11,871
-324
| -3% | -$30.8K | ﹤0.01% | 2606 |
|
|
2024
Q2 | $1.12M | Buy |
12,195
+6,075
| +99% | +$556K | ﹤0.01% | 2539 |
|
|
2024
Q1 | $555K | Buy |
6,120
+1,155
| +23% | +$105K | ﹤0.01% | 2981 |
|
|
2023
Q4 | $404K | Buy |
4,965
+78
| +2% | +$6.35K | ﹤0.01% | 3064 |
|
|
2023
Q3 | $390K | Buy |
4,887
+800
| +20% | +$63.9K | ﹤0.01% | 3022 |
|
|
2023
Q2 | $322K | Sell |
4,087
-2,619
| -39% | -$206K | ﹤0.01% | 3189 |
|
|
2023
Q1 | $521K | Sell |
6,706
-23,307
| -78% | -$1.81M | ﹤0.01% | 2878 |
|
|
2022
Q4 | $2.33M | Buy |
30,013
+16,613
| +124% | +$1.29M | ﹤0.01% | 1895 |
|
|
2022
Q3 | $901K | Buy |
13,400
+40
| +0.3% | +$2.69K | ﹤0.01% | 2462 |
|
|
2022
Q2 | $1.03M | Buy |
13,360
+1,929
| +17% | +$148K | ﹤0.01% | 2420 |
|
|
2022
Q1 | $912K | Buy |
11,431
+1,144
| +11% | +$91.3K | ﹤0.01% | 2658 |
|
|
2021
Q4 | $792K | Buy |
+10,287
| New | +$792K | ﹤0.01% | 2773 |
|
|
2021
Q3 | – | Sell |
-3,609
| Closed | -$264K | – | 4019 |
|
|
2021
Q2 | $264K | Sell |
3,609
-12
| -0.3% | -$878 | ﹤0.01% | 3495 |
|
|
2021
Q1 | $250K | Sell |
3,621
-66
| -2% | -$4.56K | ﹤0.01% | 3449 |
|
|
2020
Q4 | $245K | Sell |
3,687
-600
| -14% | -$39.9K | ﹤0.01% | 3223 |
|
|
2020
Q3 | $267K | Hold |
4,287
| – | – | ﹤0.01% | 3005 |
|
|
2020
Q2 | $267K | Buy |
4,287
+78
| +2% | +$4.86K | ﹤0.01% | 2967 |
|
|
2020
Q1 | $229K | Buy |
4,209
+600
| +17% | +$32.6K | ﹤0.01% | 2932 |
|
|
2019
Q4 | $232K | Buy |
+3,609
| New | +$232K | ﹤0.01% | 3229 |
|
|
2019
Q2 | – | Sell |
-5,100
| Closed | -$310K | – | 3585 |
|
|
2019
Q1 | $310K | Hold |
5,100
| – | – | ﹤0.01% | 2950 |
|
|
2018
Q4 | $279K | Sell |
5,100
-84,114
| -94% | -$4.6M | ﹤0.01% | 2907 |
|
|
2018
Q3 | $5.74M | Sell |
89,214
-2,292
| -3% | -$147K | 0.01% | 1132 |
|
|
2018
Q2 | $5.4M | Sell |
91,506
-769
| -0.8% | -$45.4K | 0.01% | 1150 |
|
|
2018
Q1 | $5.24M | Buy |
92,275
+673
| +0.7% | +$38.2K | 0.01% | 1134 |
|
|
2017
Q4 | $5.43M | Buy |
91,602
+3,087
| +3% | +$183K | 0.01% | 1074 |
|
|
2017
Q3 | $5.11M | Sell |
88,515
-9,011
| -9% | -$521K | 0.01% | 1069 |
|
|
2017
Q2 | $5.76M | Buy |
97,526
+362
| +0.4% | +$21.4K | 0.01% | 974 |
|
|
2017
Q1 | $5.36M | Buy |
97,164
+2,055
| +2% | +$113K | 0.01% | 991 |
|
|
2016
Q4 | $4.99M | Buy |
95,109
+2,563
| +3% | +$135K | 0.01% | 990 |
|
|
2016
Q3 | $5.32M | Buy |
92,546
+4,043
| +5% | +$232K | 0.01% | 920 |
|
|
2016
Q2 | $5.19M | Buy |
88,503
+11,806
| +15% | +$692K | 0.02% | 836 |
|
|
2016
Q1 | $4.41M | Buy |
76,697
+66
| +0.1% | +$3.8K | 0.01% | 880 |
|
|
2015
Q4 | $5.01M | Buy |
76,631
+241
| +0.3% | +$15.7K | 0.02% | 809 |
|
|
2015
Q3 | $4.81M | Sell |
76,390
-2,247
| -3% | -$141K | 0.02% | 767 |
|
|
2015
Q2 | $5.56M | Sell |
78,637
-75
| -0.1% | -$5.31K | 0.02% | 758 |
|
|
2015
Q1 | $5.53M | Sell |
78,712
-2,665
| -3% | -$187K | 0.02% | 697 |
|
|
2014
Q4 | $5.23M | Sell |
81,377
-943
| -1% | -$60.6K | 0.03% | 664 |
|
|
2014
Q3 | $5.23M | Sell |
82,320
-16,500
| -17% | -$1.05M | 0.03% | 607 |
|
|
2014
Q2 | $6.13M | Buy |
98,820
+18,467
| +23% | +$1.15M | 0.04% | 542 |
|
|
2014
Q1 | $4.69M | Buy |
+80,353
| New | +$4.69M | 0.03% | 602 |
|